Evidence map›Paper›PMID 18508039›Full record

ArticleCarbohydrate research2008

Chemo-enzymatic synthesis of C-9 acetylated sialosides.

Jana Rauvolfova, Andre Venot, Geert-Jan Boons

Abstract read
In one paragraph

Article in Carbohydrate research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Exploring the Scope of FunctionalizedMolecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jana RauvolfovaComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.
Andre Venot
Geert-Jan Boons

Funding

Synthesis/Immunological Properties of Lewis AntigensR01CA088986 · NCI · UNIVERSITY OF GEORGIA (UGA) · PI BOONS, GEERT-JAN · 2002 to 2015
$4.6M
Synthetic Oligosaccharides for Probing Infection and Innate ImmunityR01GM061761 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI BOONS, GEERT-JAN · 2000 to 2014
$4.5M
NCI NIH HHS R01 CA088986NCI NIH HHS R01 CA 88986NIGMS NIH HHS R01 GM061761
6 · The paper itself

Abstract

A chemo-enzymatic synthesis of [(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosylonic acid)-(2-->3)-O-(beta-D-galactopyranosyl)-(1-->3)-O-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)]-l-serine acetate (1) has been accomplished by a regioselective chemical acetylation of Neu5Ac (2) to give 9-O-acetylated sialic acid 3, which was enzymatically converted into CMP-Neu5,9Ac(2) (4) employing a recombinant CMP-sialic acid synthetase from Neisseria meningitis [EC 2.7.7.43]. The resulting compound was then employed for the enzymatic glycosylation of the C-3' hydroxyl of chemically prepared glycosylated amino acid 10 using recombinant rat alpha-(2-->3)-O-sialyltransferase expressed in Spodooptera frugiperda [EC 2.4.99.4] to give, after deprotection of the N(alpha)-benzyloxycarbonyl (CBz)-protecting group of serine, target compound 1. The N(alpha)-CBz-protected intermediate 11 can be employed for the synthesis of glycolipopeptides for immunization purposes.

Indexed as

Animalsbeta-Galactoside alpha-2,3-SialyltransferaseCytidine Monophosphate N-Acetylneuraminic AcidN-Acetylneuraminic AcidN-Acylneuraminate CytidylyltransferaseSialyltransferasesbeta-Galactoside alpha-2,3-SialyltransferaseCytidine Monophosphate N-Acetylneuraminic AcidN-Acetylneuraminic AcidN-Acylneuraminate CytidylyltransferaseSialyltransferases

Identifiers

PMID18508039
PMCPMC2522311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.